ARTICLE | Company News
Archemix, NascaCell deal
February 18, 2008 8:00 AM UTC
The companies expanded their 2003 deal to give NascaCell non-exclusive rights to use Archemix’s aptamer technology for mode of action studies and to validate biomarkers. The original deal gave NascaCe...